By phenotypic screening, these authors have identified small molecules, that protected podocytes against injury in vitro. This  findings identify pyrintegrin as a potential therapeutic candidate and show the use of podocyte-based screening assays for identifying novel therapeutics for proteinuric kidney diseases.

To know more of this article, follow this link :


Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.